Healthy adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) Subjects who are aware that they are susceptible to colds (3) Subjects with a low QOL questionnaire score
Exclusion criteria
Exclusion criteria: (1) Subjects who regularly intake food containing involvement ingredients at least 3 times a week. (2) Subjects who constantly use supplements or drugs affecting the immune system. (3) Subjects who regularly intake food or medicines rich in lactic acid bacteria at least 3 times a week (4) Subjects with medicine or food allergy (5) Subjects who have oral or dental problems with bleeding or develops the trouble at least once a week (6) Subjects who are under medication which may influence the outcome of the study (e.g. specific desensitization therapy) (7) Night and day shift worker or manual laborer (8) Subjects who are habitually vigorous exercise such as marathon (include professional athlete) (9) Subjects who cannot carry out the inspection procedure of various inspection by the rule during the study period (10) Subjects are undergoing medical treatment or judged as require medical treatment (11) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease and disease to affect the adrenal cortical hormone secretion) (12) Subjects having possibilities for emerging allergy related to the study (13) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (14) Subjects who intend to become pregnant or lactating (15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (16) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune function | — |
Countries
Japan
Contacts
Kewpie Corporation R&D Division